• J P Cummings, T A Ratko, and K A Matuszewski.
• Clinical Practice Advancement Center, University HealthSystem Consortium, Oak Brook, IL 60523, USA.
• Am J Manag Care. 1998 Sep 25; 4 Spec No: SP152SP166SP152-66.

ObjectiveTo evaluate the status of transmyocardial laser revascularization (TMLR) from an evidence-based perspective to help hospitals make resource management decisions.Study DesignQualitative systematic review of the clinical literature.MethodsWe searched the reference databases MEDLINE, BIOSIS, EMBASE, SciSearch, and Current Contents to identify all articles related to TMLR published between January 1985 and March 1997. We collected, analyzed, and summarized clinical studies in evidence tables.ResultsThe cumulative evidence available in the medical literature regarding the safety and effectiveness of TMLR encompasses approximately 2000 patients treated worldwide, primarily those with medically refractory angina. Preliminary data suggest that TMLR has an acceptable survival rate and effectively relieves angina in approximately 75% of patients. Data showing improved myocardial perfusion, cardiac function, or prognosis are inconclusive. The mechanism by which TMLR relieves angina is not yet known.ConclusionsEarly evidence regarding TMLR suggests it will be useful for treating patients with end-stage coronary artery disease. Definitive recommendations await critical analysis of the results of ongoing randomized clinical trials, post-market surveillance studies, and third-party payer acceptance.

28 keywords...

hide…